Tracing ACLY from cardiovascular target to liver therapy lead
By Drug Target Review
Antibodies come full circle: biopharma back at the bench
By Dr Michael Fiebig (Chief Scientific Officer at Absolute Antibody)
From lab to clinic: the rise of Radio-DARPins in oncology
By Drug Target Review
Managing CGT trials: the role of IRT from discovery to clinical development
By Cara Woodruff (Director of Product Management - IQVIA IRT)
Mast cells: new target for preventing meningitis and brain disease
Scientists at Washington University School of Medicine have discovered that mast cells – immune cells best known for triggering allergic reactions – also help protect the brain from bacterial and viral infections. This could have important implications for treating brain infections in the future.
Beyond the Lab: Clinical Trials
Explore how artificial intelligence (AI), biomarkers, and innovative trial technologies are creating a more efficient, data-driven future for drug discovery. From better patient selection to smarter trial design, see how clinical research is evolving to deliver new therapies faster.
Antibodies come full circle: biopharma back at the bench
By Dr Michael Fiebig (Chief Scientific Officer at Absolute Antibody)
Managing CGT trials: the role of IRT from discovery to…
By Cara Woodruff (Director of Product Management - IQVIA IRT)
Fixing failed drugs: AI solutions for toxicity in drug discovery…
By Dr Raminderpal Singh (Hitchhikers AI and 20/15 Visioneers)